In Peer-reviewed Journals
18. Recent Approaches towards the Development of Ru(II) Polypyridyl Complexes for Anticancer Photodynamic Therapy. A. Gandioso†, K. Purkait† and G. Gasser,* (†equal contribution), invited article for the special issue on photochemistry.
Chimia, 2021, 75, 845-855. |
17. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole 2 Ligands That Inhibit VEGFR2 Phosphorylation. Chakraborty, Ayan ; Roy, Souryadip; Chakraborty, Manas Pratim; Roy, Shantanu Saha; Purkait, Kallol; Koley, Tuhin Subhra; Das, Rahul; Acharya, Moulinath; Mukherjee, Arindam*.
Inorg. Chem. 2021, 60, 23, 18379-18394. |
16. Synthesis, structure and Cytotoxicity of N,N and N,O coordinated Ru(II) complexes of 3-aminobenzoate Schiff bases against Triple-negative breast cancer. Mukherjee, Arpan; Koley, Tuhin Subhra; Chakraborty, Ayan; Purkait, Kallol; Mukherjee, Arindam*.
Chem-Asian J. 2021, 16, 3729-3742. |
15. Synthesis, Characterization and Cytotoxicity of Morpholine-Containing Ru(II)-p-cymene complexes. Chatterjee, Rishav; Bhattacharya, Indira; Roy, Souryadip; Purkait, Kallol; Koley, Tuhin Subhra ; Gupta, Arnab; Mukherjee, Arindam*.
Inorg. Chem. 2021, 60, 12172-12185. |
14. Differences in stability, cytotoxicity and mechanism of action of Ru(II) and Pt(II) complexes of a bidentate N,O donor ligand. Moumita Maji, Sourav Acharya, Saptashi Maji, Kallol Purkait, Arnab Gupta and Arindam Mukherjee*.
Inorg. Chem. 2020, 59, 14, 10262-10274. |
13. Effect of N,N coordination and RuII halide bond in enhancing selective toxicity of a tyramine based RuII(p-cymene) complex. Arpan Mukherjee, Sourav Acharya, Kallol Purkait, Kaustav Chakraborty, Ashima Bhattacharjee, and Arindam Mukherjee*.
Inorg. Chem., 2020, 59, 9, 6581-6594. |
12. Cytotoxicity and reactivity of a redox active 1,4-quinone-pyrazole compound and its Ru(II)-p-cymene complex. Kallol Purkait and Arindam Mukherjee*.
Inorg. Chim. Acta 2020, 50, 119361. |
11. A trans-dichloridoplatinum(II) complex of a monodentate nitrogen mustard: Synthesis, stability and cytotoxicity studies. Subhendu Karmakar, Saptarshi Chatterjee, Kallol Purkait and Arindam Mukherjee.
J. Inorg. Biochem., 2020, 204, 110982. |
10. ATP7B binds Ruthenium(II)-p-cymene half-sandwich complexes: Role of steric hindrance and RuI coordination in rescuing the sequestration. Kallol Purkait, Ruturaj, Arindam Mukherjee* and Arnab Gupta*.
Inorg. Chem. 2019, 58, 22, 15659-15670. |
9. Synthesis, Structure, Stability, and Inhibition of Tubulin Polymerization by Ru-p-cymene Complexes of Trimethoxyaniline Based Schiff Bases. Sourav Acharya, Moumita Maji, Ruturaj, Kallol Purkait, Arnab Gupta and Arindam Mukherjee*.
Inorg. Chem., 2019, 58, 14, 9213-9224. |
8. Cytotoxic RuII-p-cymene complexes of an anthraimidazoledione: halide dependent solution stability, reactivity and resistance to hypoxia deactivation. Amrita Sarkar, Sourav Acharya, Kumar Khushvant, Kallol Purkait and Arindam Mukherjee*
Dalton Trans., 2019, 48, 7187-7197. |
7. Ruthenium(II) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies. Sudipta Bhattacharyya, Kallol Purkait and Arindam Mukherjee*.
Dalton Trans., 2017, 46, 8539-8554. |
6. Anticancer activity of a chelating nitrogen mustard bearing tetrachloridoplatinum(IV) complex: better stability yet equipotent to the Pt(II) analogue. Subhendu Karmakar, Saptarshi Chatterjee, Kallol Purkait and Arindam Mukherjee*.
Dalton Trans., 2016, 45, 11710-11722. |
5. Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related RuII-p-cymene complexes. Kallol Purkait, Saptarshi Chatterjee, Subhendu Karmakar and Arindam Mukherjee*.
Dalton Trans., 2016, 45, 8541-8555. |
4. Anticancer activity of a cis-dichloridoplatinum(II) complex of a chelating nitrogen mustard: insight into unusual guanine binding mode and low deactivation by glutathione. Subhendu Karmakar, Kallol Purkait, Saptarshi Chatterjee and Arindam Mukherjee*.
Dalton Trans., 2016, 45, 3599-3615. |
3. Nitric oxide release by N-(2-chloroethyl)-N-nitrosoureas: a rarely discussed mechanistic path towards their anticancer activity. Amrita Sarkar, Subhendu Karmakar, Sudipta Bhattacharyya, Kallol Purkait and Arindam Mukherjee*.
RSC Adv., 2015, 5, 2137-2146. |
2. A hypoxia efficient imidazole-based Ru(II) arene anticancer agent resistant to deactivation by glutathione. Kallol Purkait, Subhendu Karmakar, Sudipta Bhattacharyya, Saptarshi Chatterjee, Suman Kr Dey and Arindam Mukherjee*.
Dalton Trans., 2015, 44, 5969-5973. |
1. A hydroquinonebased palladium catalyst for room temperature nitro reduction in water. Alok Kumar†, Kallol Purkait†, Suman Kr. Dey, Amrita Sarkar and Arindam Mukherjee*. (†equal contribution)
RSC Adv., 2014, 4, 35233-35237. |
Conferences
International
- Symposium “5th Symposium on Advanced Biological Inorganic Chemistry”, India, 7-11 January, 2017. Poster: “Influence of Steric Hindrance on the Hydrolysis and Anticancer activity of Ru(II) p-cymene Complexes of Imidazole based Schiff Base.”
- Workshop “National Workshop on animal care, handling and management”, India, 23-31 March, 2018.
- Symposium “Chemistry interfacing with Biology and Physics”, India, 27-28 January, 2017. Poster: “Sterically Hindered Palladium(II) Complex: Anticancer Activity, Mechanism of Cell Killing and Docking Study.”
- Symposium 5th inter IISER Chemistry Meet”, India, 11-13 December, 2015. Poster: “Boon and Bane of Steric Hindrance on Cytotoxicity and Glutathione Resistance of three Structurally related RuIIp-cymene Complexes.”
- Symposium “Advances in Chemistry and their Biological and Industrial Relevance”, India, 10-11 January, 2014. Poster: “Anti-cancer activity of Metal Complexes of a Lipophilic Imidazole based Schiff base.”